Eurasian Journal of Medical and Natural Sciences 2-jild 10-son (2022) · 40–45-betlar

TUBERCULOSIS AND IRON-CONTAINING CHEMOTHERAPEUTIC DRUGS

Rakhmonova, Kamola

DOI: 10.5281/zenodo.7123203 · Manbada o'qish →

Annotatsiya

Today, in our country, special attention is paid to improving the healthcare system, including early diagnosis, treatment and prevention of tuberculosis.Some features of iron metabolism in mycobacteria are considered, as well as the varieties and pathogenesis of various variants of anemia that can develop with tuberculosis: iron deficiency (subcutaneous iron deficiency), associated with chronic disease (with relative iron deficiency) or drug-induced (variants: sideroachrestic, hemolytic, aplastic). The possibilities of correction of tuberculosis treatment regimens with the introduction of a complex compound of iron with isoniazid in order to reduce undesirable adverse reactions to isoniazid are analyzed.

tuberculosis; diagnosis, mycobacterium; iron metabolism isoniazid; ftivazid

Metadata manbasi: jurnal OAI-PMH arxivi · Sindex to'liq matnni saqlamaydi, manbaga havola beradi.